SEO URLwww.firestrike.ai/deals/faeth-therapeutics-sensei-bio-acquisition-2026-1
acquisitionAnnounced · Feb 18, 2026biotechnologySource · CredibleArticle · Factual
Sensei Bio acquires Faeth Therapeutics
David Najork · Founding Software Engineer
Published · Updated · 1 min read
Deal value
$200M
Target
Faeth Therapeutics
Austin, Texas
Acquirer
Sensei Bio
Full Acquisition
Status
Announced
Sensei Bio agreed to acquire Faeth Therapeutics. Reported deal value: $200M. Status: Announced. Sector: biotechnology. Target headquarters context: Austin, Texas, United States.
This page summarizes publicly available information about the transaction as of 2026-02-18. Figures and status may change as filings and press coverage update.
Sensei Biotherapeutics , Inc. today announced that it has acquired Faeth Therapeutics Inc. , a clinical-stage biotechnology company developing multi-node therapies that target tumor metabolism and signaling
Deal timeline
Announced
Feb 18, 2026 · biospace.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in biotechnology with a reported deal value of $200M. Figures and status may change as sources update.
Sources: biospace.com · Primary article · FireStrike proprietary index